Format
Sort by
Items per page

Send to

Choose Destination

Best matches for parkinson's epistasis:

Fine mapping and resequencing of the PARK16 locus in Parkinson's disease. Pihlstrøm L et al. J Hum Genet. (2015)

Mutations in VPS26A are not a frequent cause of Parkinson's disease. Koschmidder E et al. Neurobiol Aging. (2014)

Gene-gene and gene-environment interaction on the risk of Parkinson's disease. Singh NK et al. Curr Aging Sci. (2014)

Search results

Items: 1 to 20 of 40

1.

Alzheimer's disease susceptibility genes modify the risk of Parkinson disease and Parkinson's disease-associated cognitive impairment.

Fang L, Tang BS, Fan K, Wan CM, Yan XX, Guo JF.

Neurosci Lett. 2018 Jun 11;677:55-59. doi: 10.1016/j.neulet.2018.04.042. Epub 2018 Apr 24.

PMID:
29698690
2.

Lack of association of mortalin (HSPA9) and other mitochondria-related genes with risk of Parkinson's and Alzheimer's diseases.

Chung SJ, Kim MJ, Ryu HS, Kim J, Kim YJ, Kim K, You S, Kim SY, Lee JH.

Neurobiol Aging. 2017 Jan;49:215.e9-215.e10. doi: 10.1016/j.neurobiolaging.2016.09.017. Epub 2016 Oct 3.

PMID:
28340952
3.

A powerful and efficient two-stage method for detecting gene-to-gene interactions in GWAS.

Pecanka J, Jonker MA; International Parkinson’S Disease Genomics Consortium (IPDGC), Bochdanovits Z, Van Der Vaart AW.

Biostatistics. 2017 Jul 1;18(3):477-494. doi: 10.1093/biostatistics/kxw060.

PMID:
28334077
4.

LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in Drosophila.

Marcogliese PC, Abuaish S, Kabbach G, Abdel-Messih E, Seang S, Li G, Slack RS, Haque ME, Venderova K, Park DS.

Hum Mol Genet. 2017 Apr 1;26(7):1247-1257. doi: 10.1093/hmg/ddx030.

PMID:
28158614
5.

Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study.

Wang L, Heckman MG, Aasly JO, Annesi G, Bozi M, Chung SJ, Clarke C, Crosiers D, Eckstein G, Garraux G, Hadjigeorgiou GM, Hattori N, Jeon B, Kim YJ, Kubo M, Lesage S, Lin JJ, Lynch T, Lichtner P, Mellick GD, Mok V, Morrison KE, Quattrone A, Satake W, Silburn PA, Stefanis L, Stockton JD, Tan EK, Toda T, Brice A, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Maraganore DM, Gasser T, Krüger R, Farrer MJ, Ross OA, Sharma M; GEOPD Consortium.

Neurobiol Aging. 2017 Jan;49:217.e1-217.e4. doi: 10.1016/j.neurobiolaging.2016.09.022. Epub 2016 Oct 6.

6.

VPS35 regulates cell surface recycling and signaling of dopamine receptor D1.

Wang C, Niu M, Zhou Z, Zheng X, Zhang L, Tian Y, Yu X, Bu G, Xu H, Ma Q, Zhang YW.

Neurobiol Aging. 2016 Oct;46:22-31. doi: 10.1016/j.neurobiolaging.2016.05.016. Epub 2016 May 21.

7.

Genomic Characteristics of Genetic Creutzfeldt-Jakob Disease Patients with V180I Mutation and Associations with Other Neurodegenerative Disorders.

Lee SM, Chung M, Hyeon JW, Jeong SW, Ju YR, Kim H, Lee J, Kim S, An SS, Cho SB, Lee YS, Kim SY.

PLoS One. 2016 Jun 24;11(6):e0157540. doi: 10.1371/journal.pone.0157540. eCollection 2016.

8.

Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage.

Shi C, Zheng Z, Wang Q, Wang C, Zhang D, Zhang M, Chan P, Wang X.

PLoS One. 2016 Jun 14;11(6):e0155758. doi: 10.1371/journal.pone.0155758. eCollection 2016.

9.

Absence of the Yeast Hsp31 Chaperones of the DJ-1 Superfamily Perturbs Cytoplasmic Protein Quality Control in Late Growth Phase.

Amm I, Norell D, Wolf DH.

PLoS One. 2015 Oct 14;10(10):e0140363. doi: 10.1371/journal.pone.0140363. eCollection 2015.

10.

Clueless, a protein required for mitochondrial function, interacts with the PINK1-Parkin complex in Drosophila.

Sen A, Kalvakuri S, Bodmer R, Cox RT.

Dis Model Mech. 2015 Jun;8(6):577-89. doi: 10.1242/dmm.019208. Epub 2015 Apr 20.

11.

Fine mapping and resequencing of the PARK16 locus in Parkinson's disease.

Pihlstrøm L, Rengmark A, Bjørnarå KA, Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J, Nissbrandt H, Tysnes OB, Dietrichs E, Toft M.

J Hum Genet. 2015 Jul;60(7):357-62. doi: 10.1038/jhg.2015.34. Epub 2015 Apr 9.

PMID:
25855069
12.

Gaucher-Associated Parkinsonism.

Li Y, Li P, Liang H, Zhao Z, Hashimoto M, Wei J.

Cell Mol Neurobiol. 2015 Aug;35(6):755-61. doi: 10.1007/s10571-015-0176-8. Epub 2015 Mar 29. Review.

13.

Multifactor dimensionality reduction analysis to elucidate the cross-talk between one-carbon and xenobiotic metabolic pathways in multi-disease models.

Naushad SM, Vijayalakshmi SV, Rupasree Y, Kumudini N, Sowganthika S, Naidu JV, Ramaiah MJ, Rao DN, Kutala VK.

Mol Biol Rep. 2015 Jul;42(7):1211-24. doi: 10.1007/s11033-015-3856-z. Epub 2015 Feb 4.

PMID:
25648260
14.

Gene-gene and gene-environment interaction on the risk of Parkinson's disease.

Singh NK, Banerjee BD, Bala K, Chhillar M, Chhillar N.

Curr Aging Sci. 2014;7(2):101-9.

PMID:
25101650
15.

The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy.

Cornelissen T, Haddad D, Wauters F, Van Humbeeck C, Mandemakers W, Koentjoro B, Sue C, Gevaert K, De Strooper B, Verstreken P, Vandenberghe W.

Hum Mol Genet. 2014 Oct 1;23(19):5227-42. doi: 10.1093/hmg/ddu244. Epub 2014 May 22.

PMID:
24852371
16.

Detecting genetic interactions in pathway-based genome-wide association studies.

Huang A, Martin ER, Vance JM, Cai X.

Genet Epidemiol. 2014 May;38(4):300-9. doi: 10.1002/gepi.21803. Epub 2014 Apr 9.

PMID:
24719383
17.

MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.

Dan X, Wang C, Ma J, Feng X, Wang T, Zheng Z, Chan P.

Neurobiol Aging. 2014 Jul;35(7):1780.e7-1780.e10. doi: 10.1016/j.neurobiolaging.2014.01.025. Epub 2014 Jan 25.

PMID:
24559644
18.

Mutations in VPS26A are not a frequent cause of Parkinson's disease.

Koschmidder E, Mollenhauer B, Kasten M, Klein C, Lohmann K.

Neurobiol Aging. 2014 Jun;35(6):1512.e1-2. doi: 10.1016/j.neurobiolaging.2013.12.016. Epub 2013 Dec 27.

PMID:
24417787
19.

The NM23-H1/H2 homolog NDK-1 is required for full activation of Ras signaling in C. elegans.

Masoudi N, Fancsalszky L, Pourkarimi E, Vellai T, Alexa A, Reményi A, Gartner A, Mehta A, Takács-Vellai K.

Development. 2013 Aug;140(16):3486-95. doi: 10.1242/dev.094011.

20.

Genetic risk factors in Parkinson's disease: single gene effects and interactions of genotypes.

Göbel A, Macklin EA, Winkler S, Betensky RA, Klein C, Lohmann K, Simon DK.

J Neurol. 2012 Nov;259(11):2503-5. doi: 10.1007/s00415-012-6623-2. Epub 2012 Aug 10. No abstract available.

Supplemental Content

Loading ...
Support Center